Feasibility of proposed single-nucleotide polymorphisms as predictive markers for targeted regimens in metastatic colorectal cancer. [electronic resource]
Producer: 20130715Description: 1862-9 p. digitalISSN:- 1532-1827
- Adult
- Aged
- Angiogenesis Inhibitors -- therapeutic use
- Annexins -- genetics
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bevacizumab
- Biomarkers, Tumor -- genetics
- Cetuximab
- Colorectal Neoplasms -- drug therapy
- Disease-Free Survival
- Extracellular Signal-Regulated MAP Kinases -- biosynthesis
- Female
- Genotype
- Humans
- Leukemia Inhibitory Factor Receptor alpha Subunit -- genetics
- Male
- Matrix Metalloproteinase 9 -- biosynthesis
- Middle Aged
- Molecular Targeted Therapy
- Neoplasm Metastasis -- drug therapy
- Polymorphism, Single Nucleotide
- Proto-Oncogene Proteins -- genetics
- Proto-Oncogene Proteins p21(ras)
- ras Proteins -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.